Re-Registration

SESSION 1: Liver Cirrhosis – Variceal Bleeding Case-Based Study
• Management of Portal Hypertensive Gastropathy
• Management of Acute Variceal Bleeding

Panelist: Juferdy Kurniawan & Cosmas Rinaldi A. Lesmana

LECTURE 1: Long-Term Albumin Use in Cirrhosis: A Strategy to Enhance
Patient Survival

Speaker: Cosmas Rinaldi A. Lesmana

SESSION 2: MAFLD Case-Based Study
• MAFLD diagnosis and risk assessment
• Continuity care and treatment of MAFLD

Panelist: Irsan Hasan & Chyntia Olivia M. Jasirwan

LECTURE 2: Therapeutic Advances in Liver Inflammation: Efficacy of a New Hepatoprotective Compound

Speaker : Irsan Hasan

SESSION 3: Liver Failure Case-Based Study
• Recent Management of ALF (Acute Liver Failure)
• Recent Management of ACLF (Acute-on-Chronic Liver Failure)

Panelist: Rino Alvani Gani & Kemal Fariz Kalista

LECTURE 3: Kappa Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus

Speaker: Andri Sanityoso Sulaiman

SESSION 4: Case-Based Insights into Ascites Management in Liver Cirrhosis
• Managing Hyponatremia in Cirrhotic Ascites: Challenges and Clinical Strategies
• Optimizing Paracentesis: Evaluating the Role of Colloids in Moderate Fluid Removal

Panelist: Saut Horas H. Nababan & Imelda Maria Loho

Re-Registration

SESSION 5: Liver & Systemic Disease Case-Based Study
• Cardiac-Related Liver Dysfunction: Exploring the Heart-Liver Connection
• Hepatic Dysfunction in Sepsis: Diagnosis and Management Strategies

Panelist: Saut Horas H. Nababan & Pitt Akbar

SESSION 6: Diagnosis and Management Treatment of Biliary Tract Cancer: Case-based Study
· Identifying Symptoms and Navigating Challenges in Biliary Tract Cancer Diagnosis
· New Paradigm Treatment in Biliary Tract Cancer Management with Immunotherapy (IO)

Panelist: Irsan Hasan & Nadia Ayu Mulansari

Lecture 4 : Exploring the Use of Ursodeoxycholic Acid (UDCA) Across Cholestatic and Non-Cholestatic Disorders

Speaker : Andri Sanityoso Sulaiman

SESSION 7: HCC Case-Based Study
• Role of PIVKA-II in the Diagnosis and Surveillance of Hepatocellular Carcinoma (HCC): Emphasis on Non-B Non-C HCC
• Treatment Decision-Making for Unresectable Hepatocellular Carcinoma: Systemic Therapy or Chemoembolization

Panelist: Lianda Siregar & Imelda Maria Loho

SESSION 8: Liver Transplant Case-Based Study
• When is It Time? Indications for Liver Transplantation in Cirrhosis – MELD and Beyond
• Indications for LT in HCC Patients

Panelist: Rino Alvani Gani & Kemal Fariz Kalista

LECTURE 4: Hepatitis B WHO Guideline

Speaker: Juferdy Kurniawan

SESSION 9: Hepatitis Viral Case Based Study
• Assessing Hepatocellular Carcinoma Risk in Viral Hepatitis Patients: Strategies and Tools
• Strategies to Prevent Hepatitis B Reactivation in Patients Receiving Immunosuppressive Treatment

Panelist: Andri Sanityoso Sulaiman & Pitt Akbar